Pharmacy

Minirin Nasal Spray DDAVP

Home » Prescription Drugs 11 » Minirin Nasal Spray DDAVP

Desmopressin is used to control the amount of urine your kidneys make. Normally the amount of urine you make is controlled by a certain substance in the body called vasopressin. In people who have "water diabetes" (diabetes insipidus) or certain kinds of head injury or brain surgery the body does not make enough vasopressin. Desmopressin is a man-made form of vasopressin and is used to replace a low level of vasopressin. This medication helps to control increased thirst and too much urination due to these conditions and helps prevent dehydration.Desmopressin products applied in the nose are no longer used to control nighttime bedwetting in children because of the increased risk of developing a serious side effect (a low level of sodium in the blood).

Buy Minirin Nasal Spray DDAVP and other Prescription Drugs 11 products online at Medstore.

Buy Online at Medstore - Click Here!

About Minirin Nasal Spray DDAVP:

Product Type: Prescription Drugs 11

Minirin Nasal Spray ( DDAVP Generic Desmopressin )

Minirin Nasal Spray (DDAVP Generic Desmopressin)

DDAVP Generic Desmopressin

10mcg DDAVP Generic Desmopressin Minirin Nasal Spray

View more Prescription Drugs 11

Previous Product  Next Product

Pharmacy: Dozens of patents for name-brand drugs are due to expire within the next 14 months, and generic drugs will replace some of the most popular and widely advertised drugs used today. For millions of people worldwide, this means switching from familiar brands like Lipitor to generic equivalents. How will this affect drug companies, and what will be the impact on people who depend on expensive prescription medication? Here, a brief guide: Which drugs are scheduled to go generic? Some real blockbusters. "In the next two years, six of the 10 top-selling drugs will lose their patents," says Chris Woolston in the Los Angeles Times. Lipitor, the world's best-selling drug, which is used to lower cholesterol, will be available as a generic in November of this year. Another best-seller, the blood thinner Plavix, will lose its patent in May 2012. Other well-known drugs with expiring patents include the arthritis treatment Enbrel, the anti-psychotic Zyprexa, as well as drugs for bipolar disorder, HIV, high cholesterol, and other conditions.